There is a question nobody asks when booking cryogenic transport until something has already gone wrong.

It is not what is the dry shipper price, though that is usually the first question on the procurement form. It is not whether the vessel is IATA compliant, though that is checked on the paperwork. The question that determines outcomes, and that most clinical teams never ask until a transfer fails, is this: what is the maximum plausible journey time for this shipment, and does the vessel hold time comfortably exceed it?

Not the expected journey time. The maximum plausible one. The distinction is everything.

Why Cryogenic Transport Is a Different Problem Than Cryogenic Storage

Storage is a controlled environment problem. You select a vessel, fill it to the correct LN2 level, put it in a monitored room, and check it regularly. The variables are limited and largely under your control.

Cryogenic transport is a logistics problem. Once a charged dry shipper leaves the laboratory, you have handed operational control to a series of people and systems: couriers, airlines, customs officials, receiving staff. None of them may understand what they are carrying, what the consequences of a temperature excursion are, or that the clock started running the moment the vessel was charged.

IATA Dangerous Goods Regulations govern what dry shippers can travel by air and under what conditions. Under Special Provision A152, a correctly prepared dry shipper with no free liquid nitrogen qualifies as “Not Restricted” for air freight, a regulatory classification that eliminates the Class 2.2 hazardous goods declaration that would otherwise apply to liquid nitrogen. The A152 exemption is the mechanism that makes international biological sample transport by air practical. It is also the mechanism most frequently misunderstood or incompletely applied.

The Hold Time Calculation That Most Clinics Get Wrong

Every dry shipper has a rated hold time. For the CryoStork range from Cryolab, this spans from approximately 24 hours for the compact V2 to over ten days for the V10, a range that reflects the genuine diversity of cryogenic transport requirements across different routes and sample types.

The mistake that clinics routinely make is selecting a vessel whose rated hold time matches the expected journey. Static hold time and functional hold time are not the same figure. As noted in a USPTO patent analysis of dry shipper engineering, static hold time is measured with a full vessel, sealed, upright, in controlled conditions with no heat load from samples or handling. Functional hold time in a real clinical transfer is lower because samples, access events, and handling all contribute heat.

Hold time for planning purposes should be calculated against the maximum plausible journey time: expected transit, plus the maximum realistic customs or clearance delay for international shipments, plus an allowance for missed connections or courier depot holds, plus a safety margin. A shipment expected to take 48 hours with a realistic maximum delay of 72 hours needs a vessel rated well beyond 72 hours, not one rated for 48.

What IATA A152 Compliance Actually Requires

Compliance with IATA Special Provision A152 is not a sticker on the vessel. It is a state the vessel must be in at the time of loading, and the documentation must confirm it.

The conditions for A152 compliance are: the dry shipper must contain no free liquid nitrogen; the vessel must be correctly labelled; and the air waybill must include the verbatim phrase “Not restricted, as per Special Provision A152.” If any of those conditions is not met, the exemption does not apply and the dry shipper reverts to full IATA PI 202 dangerous goods regulation, requiring a formal Shipper’s Declaration for Dangerous Goods and Class 2.2 hazard labels. Most commercial couriers will refuse a shipment requiring PI 202 compliance without advance arrangement.

Biological samples carried inside the dry shipper must also comply with IATA Packing Instruction 650 as UN 3373 Category B biological substances, regardless of the A152 exemption on the vessel itself. A comprehensive analysis of ISO 21973 GMP-grade cryogenic transport requirements sets out how the compliance matrix works across both standards and where the two intersect, which is essential reading for any clinic managing international transfers of human reproductive material or cell therapy products.

The Charging Process: Where Most Failures Actually Begin

A dry shipper that has not been charged correctly will not perform to its rated hold time. This is the primary cause of dry shipper failure in clinical use.

Charging requires filling the vessel with liquid nitrogen and allowing the absorbent material to saturate fully. The correct indicator of full saturation is not elapsed time. It is that the vessel stops accepting liquid nitrogen. A fully saturated vessel returns poured LN2 immediately from the neck. A vessel still accepting nitrogen is still charging.

Pouring out free nitrogen before saturation is complete and loading samples into an incompletely charged vessel reduces hold time in ways that cannot be predicted from the outside. Every clinical dry shipper transfer should include a calibrated temperature data logger, not as documentation theatre but as the only way to confirm the cold chain was intact throughout the journey. This is a component of the documentation requirement under the HFEA Code of Practice for UK fertility clinics transferring human reproductive material between licensed facilities.

The Documentation Stack That Clinics Get Wrong

The regulatory framework for cryogenic transport of human reproductive material in the UK involves the HFEA Code of Practice, IATA Dangerous Goods Regulations, and for international transfers, the import and export regulations of the destination country.

The minimum documentation set for a UK clinical transfer covers: a chain-of-custody form signed by both releasing and receiving facilities; a consent verification confirming both gamete providers have authorised the transfer; a sample identity record linking physical labels on the storage device to the patient record at both ends; a temperature log covering the full transit period; and a receiving facility acceptance record. The temperature log is the document most frequently missing, and its absence is an HFEA compliance gap for which there is no retrospective remedy.

For international shipments, ESHRE guidelines on cross-border reproductive care address the clinical and regulatory framework for transfers across national boundaries, including the documentation obligations of both sending and receiving facilities.

Selecting the Right Dry Shipper

Dry shipper price is a legitimate consideration. A vessel that costs more and performs correctly on every transfer represents better value than a cheaper vessel that fails on one in twenty. The relevant calculation is not purchase price. It is cost per successful transfer, incorporating the consequences of failure.

The questions that replace the price comparison: what is the maximum plausible journey time for the routes this vessel will cover, including realistic worst-case delays? Does the rated hold time exceed that figure by a meaningful margin? What sample format will be transported and does the canister configuration accommodate it correctly? Is full A152 certification documentation available for international routes?

The CryoStork V2, V3, V4, V6 and V10 from Cryolab cover each of those requirements across hold times from 24 hours to over ten days, IATA compliance documentation, and canister configurations designed around the straw and vial formats used in reproductive medicine. The vessel is not a commodity. It is the last piece of infrastructure between a patient’s samples and an irreversible outcome. That context should set the floor for what adequate means in vessel selection.